Trial Profile
A Randomized, Open-label, Multi-center Clinical Trial to Compare Efficacy and Safety of Cyclosporine-based and Switching Cyclosporine to Tacrolimus of Two Forms-based Immunosuppressive Therapy in Renal Transplant (KTx) Recipients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2019
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 25 Nov 2015 Status changed from recruiting to discontinued according to the ClinicalTrials.gov record.
- 24 Oct 2014 New trial record